In 1992, Margolis and colleagues published a paper in the journal Nature that explored the interaction between EGFR and a newly discovered protein called Vav For their experiments, the authors expressed Vav and EGFR in cultured cells that were either stimulated with EGF or mock-treated (no EGF). Next, they immunoprecipitated Vav from the cell lysates using anti-Vav antibodies and ran the immunoprecipitates on SDS-PAGE gels. Next, they did immunoblots to detect either phospho-tyrosine (P-Tyr) or EGFR. One of their figures is reproduced below IP Ab: anti-Vav Legend: EGF: M, (K) 191- P Ab- immunoprecipitation antibody; the antibody used to pull protein complexes out of the cell lysate. Blot Ab-Blot antibody: the primary antibody that was used on the immunoblot, “anti” refers to the protein or post-translational modification that the antibody will bind to. EGFR Epidermal growth factor receptor; a receptor tyrosine kinase (RTK) EGF Epidermal growth factor; the ligand for the RTK, 92 EGF (+1-): was EGF added to the cells, yes or no? Blot Ab: anti-P-Tyr anti-EGFR (0-Molecular mass of a protein nk 1. Which lane contains a band representing Vav only? 2. Which lane contains a band representing EGFR only? 3. Which protein is bigger, Vav or EGFR? 4. In this experiment using cultured cells, is stimulation with EGF required for: a. Vav phosphorylation? b. EGFR phosphorylation? c. Binding between Vav and EGFR? 5. Why is there no band in lane 3?
Explain how you determined that those costs would fit those behavior patterns.
Description Paper question info: Think of a company with which you are familiar. Describe the company and their primary product(s)/service(s)....